Roche to Buy InterMune for $8.3 Billion

Roche Holding agreed to buy biotech company InterMune for $8.3 billion in cash, the biggest acquisition in years for the Swiss pharmaceutical giant after a string of smaller purchases.

Speak Your Mind

Subscribe to get this amazing EBOOK FREE

Real Estate 101 - Buying Your First Home!

By subscribing to this newsletter you agree to our Privacy Policy